ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Small-Cell Lung Cancer in Philadelphia, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Colorectal Cancer
Triple Negative Breast Cancer

Non-Small-Cell Lung Cancer trials near Philadelphia, PA, USA:

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...

Enrolling
Metastatic Non Small Cell Lung Cancer
Biological: LN-145

Phase 2

Iovance Biotherapeutics

Camden, New Jersey, United States and 63 other locations

and radiation therapy in treating patients with stage II-IIIB non-small cell lung cancer. Monoclonal ant ...

Active, not recruiting
Stage IIIA Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer
Drug: Carboplatin
Radiation: Intensity-Modulated Radiation Therapy

Phase 1

Rutgers The State University of New Jersey
Rutgers The State University of New Jersey

Philadelphia, Pennsylvania, United States and 2 other locations

INCMGA00012 in participants with metastatic squamous and nonsquamous non-small cell lung cancer (NSCLC)....

Active, not recruiting
Metastatic Nonsquamous Non-Small Cell Lung Cancer
Metastatic Squamous Non-Small Cell Lung Cancer
Drug: Placebo
Drug: Paclitaxel

Phase 3

Incyte
Incyte

Reading, Pennsylvania, United States and 140 other locations

and osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ...

Active, not recruiting
Non-Small Cell Lung Cancer (NSCLC)
Drug: Osimertinib
Drug: HER3-DXd

Phase 1

Daiichi Sankyo
Daiichi Sankyo

Philadelphia, Pennsylvania, United States and 30 other locations

The purpose of ARTEMIDE-Lung02 is to assess the efficacy and safety of rilvegostomig in combination with platinum-based chemotherapy for the-...

Enrolling
Non-small Cell Lung Cancer
Drug: Nab-paclitaxel
Drug: Pembrolizumab

Phase 3

AstraZeneca
AstraZeneca

Camden, New Jersey, United States and 290 other locations

combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small c ...

Active, not recruiting
Non-Small-Cell Lung Cancer
Drug: Amivantamab
Drug: Carboplatin

Phase 1

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

Philadelphia, Pennsylvania, United States and 72 other locations

(MRD) is an effective treatment approach for locally advanced non-small cell lung cancer (LA-NSCLC). The...

Enrolling
Non-Small Cell Lung Cancer
Drug: Sotorasib
Drug: Durvalumab

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Allentown, Pennsylvania, United States and 10 other locations

Locations recently updated

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Telisotuzumab vedotin

Phase 2

AbbVie
AbbVie

Pennington, New Jersey, United States and 252 other locations

alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Pemetrexed/Carboplatin
Drug: Pemetrexed/Cisplatin

Phase 3

AstraZeneca
AstraZeneca

Philadelphia, Pennsylvania, United States and 152 other locations

This is a Phase III, randomised, double-blind, multicentre, international study assessing the efficacy and safety of durvalumab (MEDI4736) in combina...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Oleclumab
Drug: Durvalumab

Phase 3

AstraZeneca
AstraZeneca

Philadelphia, Pennsylvania, United States and 202 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems